Mobocertinib in previously treated patients with EGFR exon 20 insertion (ex20ins) + metastatic NSCLC (mNSCLC): updated results from a phase 1/2 study. (April 2023) - Popat, Sanjay; Ramalingam, Suresh; Zhou, Caicun; Kim, Tae; Yang, James; Riely, Gregory; Mekhail, Tarek; Nguyen, Danny; Garcia Campelo, Maria Rosario; Felip, Enriqueta; Misch, Daniel; Kaur, Manmit; et al.